肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理

2020-11-10 意大利血液学和肿瘤学协会 J Vasc Access . 2020 Nov 10;

中心静脉通路

2020年11月，意大利血液学和肿瘤学协会(AIEOP)发布了儿童血液肿瘤患者中心静脉通路装置的管理指南。中心静脉通路装置(CVADs)对于儿童肿瘤血液患者的诊断和治疗具有重要意义，本文主要针对儿童血

中文标题：

2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理

英文标题：

Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease

发布机构：

意大利血液学和肿瘤学协会

发布日期：

2020-11-10

简要介绍：

2020年11月，意大利血液学和肿瘤学协会(AIEOP)发布了儿童血液肿瘤患者中心静脉通路装置的管理指南。中心静脉通路装置(CVADs)对于儿童肿瘤血液患者的诊断和治疗具有重要意义，本文主要针对儿童血液肿瘤患者中心静脉通路装置的管理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=703ec1c00201a57f, title=2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理, enTitle=Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease, guiderFrom=J Vasc Access . 2020 Nov 10;, authorId=0, author=, summary=2020年11月，意大利血液学和肿瘤学协会(AIEOP)发布了儿童血液肿瘤患者中心静脉通路装置的管理指南。中心静脉通路装置(CVADs)对于儿童肿瘤血液患者的诊断和治疗具有重要意义，本文主要针对儿童血, cover=https://img.medsci.cn/20201128/1606493709216_2020535.jpg, journalId=0, articlesId=null, associationId=460, associationName=意大利血液学和肿瘤学协会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Nov 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，意大利血液学和肿瘤学协会(AIEOP)发布了儿童血液肿瘤患者中心静脉通路装置的管理指南。中心静脉通路装置(CVADs)对于儿童肿瘤血液患者的诊断和治疗具有重要意义，本文主要针对儿童血液肿瘤患者中心静脉通路装置的管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=50964, tagName=中心静脉通路)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=50964, guiderKeyword=中心静脉通路, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10622, appHits=106, showAppHits=0, pcHits=713, showPcHits=10516, likes=2, shares=6, comments=11, approvalStatus=1, publishedTime=Sat Nov 28 00:31:04 CST 2020, publishedTimeString=2020-11-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 28 00:15:17 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 20:26:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理.pdf)])
2020 AIEOP指南：儿童血液肿瘤患者中心静脉通路装置的管理.pdf
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079059, encodeId=74fb10e9059c7, content=并发症 血栓 指南 英文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Dec 11 15:27:19 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078906, encodeId=be3c10e890687, content=想了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 10 23:10:45 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056665, encodeId=b03f1056665a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Sep 30 23:51:57 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968733, encodeId=1bc1968e3373, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f31918292, createdName=naizi2, createdTime=Wed May 26 20:40:05 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964179, encodeId=98919641e9a4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:46:04 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-12-11 一己怀

    并发症 血栓 指南 英文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079059, encodeId=74fb10e9059c7, content=并发症 血栓 指南 英文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Dec 11 15:27:19 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078906, encodeId=be3c10e890687, content=想了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 10 23:10:45 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056665, encodeId=b03f1056665a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Sep 30 23:51:57 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968733, encodeId=1bc1968e3373, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f31918292, createdName=naizi2, createdTime=Wed May 26 20:40:05 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964179, encodeId=98919641e9a4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:46:04 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-12-10 RENYUQIONG200798

    想了解

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079059, encodeId=74fb10e9059c7, content=并发症 血栓 指南 英文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Dec 11 15:27:19 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078906, encodeId=be3c10e890687, content=想了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 10 23:10:45 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056665, encodeId=b03f1056665a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Sep 30 23:51:57 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968733, encodeId=1bc1968e3373, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f31918292, createdName=naizi2, createdTime=Wed May 26 20:40:05 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964179, encodeId=98919641e9a4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:46:04 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-09-30 一己怀

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079059, encodeId=74fb10e9059c7, content=并发症 血栓 指南 英文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Dec 11 15:27:19 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078906, encodeId=be3c10e890687, content=想了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 10 23:10:45 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056665, encodeId=b03f1056665a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Sep 30 23:51:57 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968733, encodeId=1bc1968e3373, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f31918292, createdName=naizi2, createdTime=Wed May 26 20:40:05 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964179, encodeId=98919641e9a4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:46:04 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-05-26 naizi2

    棒棒的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079059, encodeId=74fb10e9059c7, content=并发症 血栓 指南 英文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Dec 11 15:27:19 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078906, encodeId=be3c10e890687, content=想了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Fri Dec 10 23:10:45 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056665, encodeId=b03f1056665a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Sep 30 23:51:57 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968733, encodeId=1bc1968e3373, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f31918292, createdName=naizi2, createdTime=Wed May 26 20:40:05 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964179, encodeId=98919641e9a4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:46:04 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-05-10 ms7000000855425149

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中心静脉血管通路装置安全管理专家共识（2019版）

暂未更新 · 2020-04-30

2020 ASA实践指南：中心静脉通路

美国麻醉医师协会(ASA,American Society of Anesthesiologists) · 2019-12-10

拓展阅读

2020 ASA实践指南：中心静脉通路

美国麻醉医师协会(ASA,American Society of Anesthesiologists) · 2019-12-10

中心静脉血管通路装置安全管理专家共识（2019版）

暂未更新 · 2020-04-30

2023 ACR适宜性标准：中心静脉通路装置和部位选择

美国放射学会(ACR,American College of Radiology) · 2023-05-20